Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BFRIW | US
0
0%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
0.02
0.02
0.03
0.02
Biofrontera Inc. a biopharmaceutical company develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn Massachusetts.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
695.7%1 month
719.6%3 months
525.9%6 months
424.8%-
-
-
0.13
0.07
-
-
-
-18.32M
-
-
-
-64.69
-
34.00
-149.41
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.02
Range1M
0.02
Range3M
0.03
Rel. volume
6.61
Price X volume
1.35K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.103 | 0 | -0.96% | n/a | 2.46% |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.98 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 17.21 | - |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | - | 12.15 | - |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 525.91 | 68.34 | Riskier |
Debt to Equity | 0.13 | -1.00 | Expensive |
Debt to Assets | 0.07 | 0.48 | Cheaper |
Market Cap | - | 5.31B | - |